Singapore markets open in 2 hours 3 minutes

Abbott Laboratories (ABT)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
123.27-0.55 (-0.44%)
At close: 04:02PM EST
122.00 -1.27 (-1.03%)
After hours: 05:43PM EST
Full screen
Trade prices are not sourced from all markets
Previous close123.82
Bid123.08 x 1000
Ask123.88 x 800
Day's range121.60 - 124.62
52-week range105.36 - 142.60
Avg. volume5,693,985
Market cap217.977B
Beta (5Y monthly)0.70
PE ratio (TTM)30.59
EPS (TTM)4.03
Earnings date26 Jan 2022
Forward dividend & yield1.88 (1.49%)
Ex-dividend date13 Jan 2022
1y target est145.18
  • Zacks

    Is a Surprise Coming for Abbott (ABT) This Earnings Season?

    Abbott (ABT) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

  • Motley Fool

    2 Healthcare Stocks You Can Buy and Hold for the Next Decade

    Abbott is a major pharmaceutical company best known for its medical devices, diagnostics, and pediatric and adult nutritional products -- think Pedialyte or Similac. This year, it's being crowned as a dividend king -- meaning the company has increased its annual dividend for 50 consecutive years. Excluding COVID-testing-related sales, Abbott still boasts a nearly 12% increase over pre-pandemic 2019 sales for the quarter.

  • Motley Fool

    3 Things About Abbott Laboratories That Smart Investors Know

    When it comes to underrated healthcare stocks that smart investors love, Abbott Laboratories (NYSE: ABT) takes the cake. On the contrary, it's exactly Abbott's willingness to compete in these spaces that makes the company one of the sturdiest. Given that Abbott has a market cap of about $238 billion and trailing revenue of $42.3 billion, it shouldn't surprise anyone that the business sometimes struggles to grow as aggressively as a smaller competitor might.